Back in Person: Frontiers in Medicinal Chemistry 2023
暂无分享,去创建一个
G. Hessler | Franca-Maria Klingler | M. Gehringer | Eleonora Diamanti | M. Schiedel | Thierry Langer | M. Méndez | J. Lefranc | Felix Pape | Philipp Barbie | Andrea Unzue Lopez | Matthias Schiedel
[1] Lukas Zeisel,et al. Cyclic Dichalcogenides Extend the Reach of Bioreductive Prodrugs to Harness Thiol/Disulfide Oxidoreductases: Applications to seco-Duocarmycins Targeting the Thioredoxin System , 2023, ACS central science.
[2] E. Salah,et al. Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine , 2023, Journal of medicinal chemistry.
[3] G. Wang,et al. Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors , 2022, Journal of medicinal chemistry.
[4] P. Bogner,et al. BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor , 2022, Journal of medicinal chemistry.
[5] A. Borkhardt,et al. Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity. , 2022, Journal of medicinal chemistry.
[6] C. Lemmen,et al. Chemical space docking enables large-scale structure-based virtual screening to discover ROCK1 kinase inhibitors , 2022, Nature Communications.
[7] A. Waterson,et al. Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRASG12C Inhibitor , 2022, Journal of medicinal chemistry.
[8] D. Kaldre,et al. Inverse hydride shuttle catalysis enables the stereoselective one-step synthesis of complex frameworks , 2022, Nature Chemistry.
[9] S. Wessler,et al. Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases , 2022, Journal of medicinal chemistry.
[10] D. Ricklin,et al. Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors , 2022, Nature Communications.
[11] D. Leonori,et al. Photoexcited nitroarenes for the oxidative cleavage of alkenes , 2022, Nature.
[12] K. Houk,et al. A concise synthesis of tetrodotoxin , 2022, Science.
[13] M. Windbergs,et al. Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment. , 2022, Journal of medicinal chemistry.
[14] M. Schiedel,et al. Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2. , 2022, ACS chemical biology.
[15] Jérémy Merad,et al. Direct Stereodivergent Olefination of Carbonyl Compounds with Sulfur Ylides , 2022, Journal of the American Chemical Society.
[16] A. Rentmeister,et al. Photocaged 5′ cap analogues for optical control of mRNA translation in cells , 2022, Nature Chemistry.
[17] K. Ashe,et al. Caspase-2 Inhibitor Blocks Tau Truncation and Restores Excitatory Neurotransmission in Neurons Modeling FTDP-17 Tauopathy. , 2022, ACS chemical neuroscience.
[18] M. Bischoff,et al. Regio‐ and Stereoselective Epoxidation and Acidic Epoxide Opening of Antibacterial and Antiplasmodial Chlorotonils Yield Highly Potent Derivatives , 2022, Angewandte Chemie.
[19] Hana Imrichová,et al. Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders , 2022, bioRxiv.
[20] A. Rentmeister,et al. Chemo-Enzymatic Modification of the 5' Cap To Study mRNAs. , 2022, Accounts of chemical research.
[21] H. Natsugari,et al. Axial chirality and affinity at the GABAA receptor of triazolobenzodiazepines. , 2022, Bioorganic & medicinal chemistry.
[22] Y. Orba,et al. Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19 , 2022, Journal of medicinal chemistry.
[23] Julian E. Fuchs,et al. A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo , 2022, Nature Communications.
[24] C. Schofield,et al. Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS‐CoV‐2 Papain‐Like Protease , 2022, ChemMedChem.
[25] John D Lambris,et al. Compstatins: the dawn of clinical C3-targeted complement inhibition. , 2022, Trends in pharmacological sciences.
[26] E. Kostenis,et al. A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands, New Drug Leads and PROTACs , 2021, Angewandte Chemie.
[27] M. Dreyer,et al. Rational Design of Highly Potent, Selective, and Bioavailable SGK1 Protein Kinase Inhibitors for the Treatment of Osteoarthritis. , 2021, Journal of medicinal chemistry.
[28] R. Hartmann,et al. Substrate‐Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors , 2021, Angewandte Chemie.
[29] H. Natsugari,et al. Atropisomeric Properties of 9-Methyl-1,4-benzodiazepin-2-ones , 2021, Synthesis.
[30] D. Trauner,et al. Photoswitchable Serotonins for Optical Control of the 5-HT2A Receptor. , 2021, Angewandte Chemie.
[31] Sheridan M. Hoy. Pegcetacoplan: First Approval , 2021, Drugs.
[32] K. Gajiwala,et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19 , 2021, Science.
[33] M. Bogyo,et al. Selective activation of PFKL suppresses the phagocytic oxidative burst , 2021, Cell.
[34] S. Knapp,et al. Discovery of a Potent and Highly Isoform-Selective Inhibitor of the Neglected Ribosomal Protein S6 Kinase Beta 2 (S6K2) , 2021, Cancers.
[35] E. Isacoff,et al. Selective Photoswitchable Allosteric Agonist of a G Protein-Coupled Receptor , 2021, Journal of the American Chemical Society.
[36] K. Becker,et al. Selective, Modular Probes for Thioredoxins Enabled by Rational Tuning of a Unique Disulfide Structure Motif. , 2021, Journal of the American Chemical Society.
[37] J. Kim,et al. A radical approach for the selective C–H borylation of azines , 2021, Nature.
[38] Andrew J. Bannister,et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia , 2021, Nature.
[39] M. Steinmetz,et al. In Vivo Photocontrol of Microtubule Dynamics and Integrity, Migration and Mitosis, by the Potent GFP-Imaging-Compatible Photoswitchable Reagents SBTubA4P and SBTub2M , 2021, bioRxiv.
[40] G. Wolber,et al. Chemical Evolution of Antivirals Against Enterovirus D68 through Protein‐Templated Knoevenagel Reactions , 2021, Angewandte Chemie.
[41] R. Hartmann,et al. Phosphonate as Stable Zinc-binding Group for Inhibitors of Clostridial Collagenase H (ColH) as Pathoblocker Agents. , 2021, ChemMedChem.
[42] P. Cramer,et al. Small-molecule inhibitors of human mitochondrial DNA transcription , 2020, Nature.
[43] M. Steinmetz,et al. A Robust, GFP-Orthogonal Photoswitchable Inhibitor Scaffold Extends Optical Control over the Microtubule Cytoskeleton. , 2020, Cell chemical biology.
[44] J. Meiler,et al. Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs) , 2020, Angewandte Chemie.
[45] Christian N. Cunningham,et al. Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling. , 2020, Cell reports.
[46] Julian E. Fuchs,et al. PI by NMR: Probing CH–π Interactions in Protein–Ligand Complexes by NMR Spectroscopy , 2020, Angewandte Chemie.
[47] Thomas M. Smith,et al. Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases. , 2020, Journal of medicinal chemistry.
[48] R. Müller,et al. Production optimization and biosynthesis revision of corallopyronin A, a potent anti-filarial antibiotic. , 2019, Metabolic engineering.
[49] William Farnaby,et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design , 2019, Nature Chemical Biology.
[50] S. Laufer,et al. Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology. , 2018, Journal of medicinal chemistry.
[51] R. Hartmann,et al. Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture Healing. , 2019, Journal of medicinal chemistry.
[52] R. Hartmann,et al. Highly Potent 17β-HSD2 Inhibitors with a Promising Pharmacokinetic Profile for Targeted Osteoporosis Therapy. , 2018, Journal of medicinal chemistry.
[53] R. Krüger,et al. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps , 2018, Science Immunology.
[54] R. Konrat,et al. Late metabolic precursors for selective aromatic residue labeling , 2018, Journal of Biomolecular NMR.
[55] M. Pérez,et al. Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease , 2018, Molecular Neurobiology.
[56] A. Kirschning,et al. Discovery and Total Synthesis of Natural Cystobactamid Derivatives with Superior Activity against Gram-Negative Pathogens. , 2017, Angewandte Chemie.
[57] Qingzhong Hu,et al. Lead Optimization Generates CYP11B1 Inhibitors of Pyridylmethyl Isoxazole Type with Improved Pharmacological Profile for the Treatment of Cushing's Disease. , 2017, Journal of medicinal chemistry.
[58] K. Zahs,et al. Caspase-2 cleavage of tau reversibly impairs memory , 2016, Nature Medicine.
[59] Elisa de Stanchina,et al. Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor , 2016, Nature.
[60] R. Müller,et al. Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activity. , 2014, Angewandte Chemie.
[61] Qingzhong Hu,et al. Potent 11β-hydroxylase inhibitors with inverse metabolic stability in human plasma and hepatic S9 fractions to promote wound healing. , 2014, Journal of medicinal chemistry.
[62] R. Hartmann,et al. Lead optimization of 17β-HSD1 inhibitors of the (hydroxyphenyl)naphthol sulfonamide type for the treatment of endometriosis. , 2012, Journal of medicinal chemistry.
[63] R. Hartmann,et al. In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivatives. , 2008, Journal of medicinal chemistry.
[64] M. Gütschow,et al. Azadipeptide nitriles: highly potent and proteolytically stable inhibitors of papain-like cysteine proteases. , 2008, Angewandte Chemie.
[65] R. Hartmann,et al. Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases. , 2008, Journal of medicinal chemistry.
[66] R. Hartmann,et al. Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl)piperidine-2,6-diones. , 1986, Journal of medicinal chemistry.